EpilepsyGTx
Developing gene therapies to transform the management of focal refractory epilepsy (FRE).
HQ location
Cambridge, United Kingdom
Website
Enterprise value
$40—60m
Company register number
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
* | $10.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads